[Randomized head-to-head comparison of pitavastatin, atorvastatin, and rosuvastatin for safety and efficacy (quantity and quality of LDL): -- the PATROL trial]

Nihon Naika Gakkai Zasshi. 2011 Dec 10;100(12):3679-86. doi: 10.2169/naika.100.3679.

[Article in Japanese]

Authors

Keijiro Saku¹, Bo Zhang, Keita Noda

Affiliation

¹ Department of Cardiology, Fukuoka University School of Medicine, Japan.

PMID: 22338904
DOI: 10.2169/naika.100.3679

No abstract available

Publication types

Comparative Study
Randomized Controlled Trial

MeSH terms

Atorvastatin
Cholesterol, LDL / blood*
Fluorobenzenes / adverse effects
Fluorobenzenes / therapeutic use*
Heptanoic Acids / adverse effects
Heptanoic Acids / therapeutic use*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypercholesterolemia / drug therapy*
Pyrimidines / adverse effects
Pyrimidines / therapeutic use*
Pyrroles / adverse effects
Pyrroles / therapeutic use*
Quinolines / adverse effects
Quinolines / therapeutic use*
Rosuvastatin Calcium
Sulfonamides / adverse effects
Sulfonamides / therapeutic use*

Substances

Cholesterol, LDL
Fluorobenzenes
Heptanoic Acids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pyrimidines
Pyrroles
Quinolines
Sulfonamides
Rosuvastatin Calcium
Atorvastatin
pitavastatin